Report

Global Antibiotics Market Size study, by Action Mechanism (Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, and Mycolic Acid Inhibitors) Drug Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolide, Carbapenem, Aminoglycoside, Sulfonamide, and 7-ACA) and Regional Forecasts 2021-2027

  • Publish Date: Mar,2022
  • Report ID: QI037
  • Page : 250
  • Report Type : PDF (Email)
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Antibiotics Market, by Region, 2019-2027 (USD Billion)
1.2.2. Antibiotics Market, by Action Mechanism, 2019-2027 (USD Billion)
1.2.3. Antibiotics Market, by Drug Class, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Antibiotics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Antibiotics Market Dynamics
3.1. Antibiotics Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Investments in research and development of new antibiotic drugs
3.1.1.2. Increasing growth in the incidences of infection and chronic diseases
3.1.1.3. Constant support from the governments
3.1.2. Market Challenges
3.1.2.1. Strict government regulations for the approval of new medicines
3.1.2.2. Certain side effects of antibiotics
3.1.3. Market Opportunities
3.1.3.1. Prolonged increase in the demand of antibiotics
Chapter 4. Global Antibiotics Market Industry Analysis
4.1. Porters 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porters 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Antibiotics Market, by Action Mechanism
5.1. Market Snapshot
5.2. Global Antibiotics Market by Action Mechanism , Performance - Potential Analysis
5.3. Global Antibiotics Market Estimates & Forecasts by Action Mechanism 2018-2027 (USD Billion)
5.4. Antibiotics Market, Sub Segment Analysis
5.4.1. Cell Wall Synthesis Inhibitors
5.4.2. Protein Synthesis Inhibitors
5.4.3. DNA Synthesis Inhibitors
5.4.4. RNA Synthesis Inhibitors
5.4.5. Mycolic Acid Inhibitors
5.4.6. Others
Chapter 6. Global Antibiotics Market, by Drug Class
6.1. Market Snapshot
6.2. Global Antibiotics Market by Drug Class, Performance - Potential Analysis
6.3. Global Antibiotics Market Estimates & Forecasts by Drug Class 2018-2027 (USD Billion)
6.4. Antibiotics Market, Sub Segment Analysis
6.4.1. Cephalosporin
6.4.2. Penicillin
6.4.3. Fluoroquinolone
6.4.4. Macrolide
6.4.5. Carbapenem
6.4.6. Aminoglycoside
6.4.7. Sulfonamide
6.4.8. 7-ACA
6.4.9. Others
Chapter 7. Global Antibiotics Market, Regional Analysis
7.1. Antibiotics Market, Regional Market Snapshot
7.2. North America Antibiotics Market
7.2.1. U.S. Antibiotics Market
7.2.1.1. Action Mechanism breakdown estimates & forecasts, 2018-2027
7.2.1.2. Drug Class breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Antibiotics Market
7.3. Europe Antibiotics Market Snapshot
7.3.1. U.K. Antibiotics Market
7.3.2. Germany Antibiotics Market
7.3.3. France Antibiotics Market
7.3.4. Spain Antibiotics Market
7.3.5. Italy Antibiotics Market
7.3.6. Rest of Europe Antibiotics Market
7.4. Asia-Pacific Antibiotics Market Snapshot
7.4.1. China Antibiotics Market
7.4.2. India Antibiotics Market
7.4.3. Japan Antibiotics Market
7.4.4. Australia Antibiotics Market
7.4.5. South Korea Antibiotics Market
7.4.6. Rest of Asia Pacific Antibiotics Market
7.5. Latin America Antibiotics Market Snapshot
7.5.1. Brazil Antibiotics Market
7.5.2. Mexico Antibiotics Market
7.6. Rest of The World Antibiotics Market

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Allergan (AbbVie Inc.)
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Merck & Co., Inc
8.2.3. Cumberland Pharmaceuticals, Inc.
8.2.4. GlaxoSmithKline plc
8.2.5. Novartis AG
8.2.6. Melinta Therapeutics
8.2.7. Teva Pharmaceutical Industries Ltd.
8.2.8. Nabriva Therapeutics plc
8.2.9. Mylan N.V.
8.2.10. Abbott Laboratories
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption